The latest biotechnology news | Bio News
BIO Investor forum IPO

BIO Investor Forum panel breaks down when, what, and why of IPOs

Biotech firms weighing an initial public offering (IPO) must consider timing, interest in ...
Read More
BIO's Crystal Kuntz at the 2024 BIO Investor Forum in San Francisco

BIF 2024: ‘The IRA really disrupted how we think’

The Inflation Reduction Act (IRA) has been top of mind for many in ...
Read More
Senior couple medicating at home with medical prescription

As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment

Prescription drug coverage in Medicare will see sweeping changes – for both health ...
Read More
IMG_7356

BIO Investor Forum opens with encouraging news on financing

The tide has been rising in biotech investment in 2024—though it has not ...
Read More
Neurodegenerative disease panel at the BIO Investor Forum 2024 in San Francisco

BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?

There is a great degree of renewed optimism for drug development in the ...
Read More
BIO investor market

How to follow the 2024 BIO Investor Forum in San Francisco

Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

IMG_7356

BIO Investor Forum opens with encouraging news on financing

The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in the ...
Read More

LATEST NEWS

BIO Events

BIO Investor Forum panel breaks down when, what, and why of IPOs

Biotech firms weighing an initial public offering (IPO) must consider timing, interest in their product, the macro environment—and whether they really need all the headaches, ...
BIO Events

BIF 2024: ‘The IRA really disrupted how we think’

The Inflation Reduction Act (IRA) has been top of mind for many in the biotech industry. The first round of price negotiations and the impending ...
BIO's View

As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment

Prescription drug coverage in Medicare will see sweeping changes – for both health plans and for the millions of American seniors they serve – despite ...
BIO Events

BIO Investor Forum opens with encouraging news on financing

The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in the ...
BIO Events

BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?

There is a great degree of renewed optimism for drug development in the neurodegenerative disease space. “Some of that optimism has obviously come from the ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

AGRICULTURE

Climate Change

BIO priorities

What to know about BIO’s 7 Core Strategic Priorities

With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve ...
Read More

Federal Policy

State Policy

International

Bio's View

Scroll to Top